Further Investigation of the Role of <i>ACYP2</i> and <i>WFS1</i> Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients.

Drögemöller, Britt I; Brooks, Beth; Critchley, Carol; Monzon, José G; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Hayden, Michael R; Gelmon, Karen A; Carleton, Bruce C; Ross, Colin J D

Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients.

Drögemöller, Britt I; Brooks, Beth; Critchley, Carol; Monzon, José G; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Hayden, Michael R; Gelmon, Karen A; Carleton, Bruce C; Ross, Colin J D.

Afiliación

Drögemöller BI; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Brooks B; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Critchley C; Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada.
Monzon JG; Neuro-Otology Unit, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Wright GEB; Tom Baker Cancer Centre, Calgary, AB, Canada.
Liu G; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Renouf DJ; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Kollmannsberger CK; Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre-University Health Network and University of Toronto, Toronto, Ontario, Canada.
Bedard PL; BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada.
Hayden MR; BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada.
Gelmon KA; Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.
Carleton BC; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Ross CJD; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Clin Cancer Res ; 24(8): 1866-1871, 2018 04 15.

Article en En | MEDLINE | ID: mdl-29358504

Asunto(s)

Ácido Anhídrido Hidrolasas/genética; Antineoplásicos/efectos adversos; Cisplatino/efectos adversos; Proteínas de la Membrana/genética; Variantes Farmacogenómicas; Neoplasias Testiculares/tratamiento farmacológico; Neoplasias Testiculares/genética; Ácido Anhídrido Hidrolasas/metabolismo; Adulto; Alelos; Antineoplásicos/uso terapéutico; Estudios de Casos y Controles; Cisplatino/uso terapéutico; Variación Genética; Genotipo; Humanos; Masculino; Proteínas de la Membrana/metabolismo; Persona de Mediana Edad; Oportunidad Relativa; Pruebas de Farmacogenómica; Neoplasias Testiculares/diagnóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Cisplatino / Ácido Anhídrido Hidrolasas / Variantes Farmacogenómicas / Proteínas de la Membrana / Antineoplásicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google